Conclusions of the research team from the Harvard School of Public Health and the University of California was found, the risk of death from prostate cancer in men smokers reach 61 percent. So does the risk for the occurrence of the recurrence of disease after therapy.
Among smokers and non smokers who kankernya not spread when diagnosed, or in a language called medical non-metastatic cancer, the risk of death that confronts the smoker reaches 80 percent.
However, smokers who've stopped for 10 years or more when being diagnosed with prostate cancer have an equal opportunity with men not smokers, both in the recurrence and risk of death.
"This research Data as it is just a bit of a relief that we know of to reduce the risk of death from prostate cancer. It also could be a reason not to smoke, "says Edward Giovannucci, Professor of nutrition and epidemiology from Harvard.
The study examines health data of 5.366 man who was diagnosed with prostate cancer between 1986 and 2006. During this period, 1,630 died, 524 (32 percent) due to prostate cancer and 416 (26 percent) due to heart disease.
Prostate cancer is the most common type of cancer afflicting man in America and about 1 in 6 men in her life.